10-K Filing

HCA HEALTHCARE, INC. CIK: 860730 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001193125-22-046707`
Period End Date	20211231
Filing Date	20220218
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	d32297d10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 57 Cash Flow Statement 101 Stockholders Equity 32 Comprehensive Income 45

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Debt issuance costs	`DeferredFinanceCostsNoncurrentNet`	$248.00M	USD	Point-in-time
Debt issuance costs	`DeferredFinanceCostsNoncurrentNet`	$236.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.79B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.45B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	339.43M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$8.10B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	305.48M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$7.05B	USD	Point-in-time
Inventories	`InventoryNet`	$1.99B	USD	Point-in-time
Inventories	`InventoryNet`	$2.02B	USD	Point-in-time
Other	`OtherAssetsCurrent`	$1.46B	USD	Point-in-time
Other	`OtherAssetsCurrent`	$2.01B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.54B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.33B	USD	Point-in-time
Land	`Land`	$2.50B	USD	Point-in-time
Land	`Land`	$2.27B	USD	Point-in-time
Buildings	`BuildingsAndImprovementsGross`	$19.21B	USD	Point-in-time
Buildings	`BuildingsAndImprovementsGross`	$18.47B	USD	Point-in-time
Equipment	`MachineryAndEquipmentGross`	$28.26B	USD	Point-in-time
Equipment	`MachineryAndEquipmentGross`	$27.08B	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$1.50B	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$1.39B	USD	Point-in-time
Property and equipment, at cost	`PropertyPlantAndEquipmentGross`	$49.32B	USD	Point-in-time
Property and equipment, at cost	`PropertyPlantAndEquipmentGross`	$51.35B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$26.12B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$27.29B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$24.06B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.20B	USD	Point-in-time
Investments of insurance subsidiaries	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$438.00M	USD	Point-in-time
Investments of insurance subsidiaries	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$388.00M	USD	Point-in-time
Investments in and advances to affiliates	`EquityMethodInvestments`	$448.00M	USD	Point-in-time
Investments in and advances to affiliates	`EquityMethodInvestments`	$422.00M	USD	Point-in-time
Goodwill and other intangible assets	`IntangibleAssetsNetIncludingGoodwill`	$9.54B	USD	Point-in-time
Goodwill and other intangible assets	`IntangibleAssetsNetIncludingGoodwill`	$8.58B	USD	Point-in-time
Goodwill and other intangible assets	`IntangibleAssetsNetIncludingGoodwill`	$7.95B	USD	Point-in-time
Goodwill and other intangible assets	`IntangibleAssetsNetIncludingGoodwill`	$8.27B	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$2.11B	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$2.02B	USD	Point-in-time
Other	`OtherAssetsNoncurrent`	$598.00M	USD	Point-in-time
Other	`OtherAssetsNoncurrent`	$546.00M	USD	Point-in-time
Total assets	`Assets`	$45.06B	USD	Point-in-time
Total assets	`Assets`	$50.74B	USD	Point-in-time
Total assets	`Assets`	$47.49B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.54B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.11B	USD	Point-in-time
Accrued salaries	`AccruedSalariesCurrent`	$1.72B	USD	Point-in-time
Accrued salaries	`AccruedSalariesCurrent`	$1.91B	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$3.32B	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$3.24B	USD	Point-in-time
Long-term debt due within one year	`LongTermDebtCurrent`	$237.00M	USD	Point-in-time
Long-term debt due within one year	`LongTermDebtCurrent`	$209.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.58B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.70B	USD	Point-in-time
Long-term debt, less debt issuance costs and discounts of $248 and $236	`LongTermDebtNoncurrent`	$34.34B	USD	Point-in-time
Long-term debt, less debt issuance costs and discounts of $248 and $236	`LongTermDebtNoncurrent`	$30.80B	USD	Point-in-time
Professional liability risks	`ProfessionalLiabilityRisks`	$1.49B	USD	Point-in-time
Professional liability risks	`ProfessionalLiabilityRisks`	$1.51B	USD	Point-in-time
Right-of-use operating lease obligations	`OperatingLeaseLiabilityNoncurrent`	$1.75B	USD	Point-in-time
Right-of-use operating lease obligations	`OperatingLeaseLiabilityNoncurrent`	$1.67B	USD	Point-in-time
Income taxes and other liabilities	`IncomeTaxesAndOtherLiabilities`	$2.06B	USD	Point-in-time
Income taxes and other liabilities	`IncomeTaxesAndOtherLiabilities`	$1.94B	USD	Point-in-time
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 305,476,800 shares 2021 and 339,425,600 shares 2020	`CommonStockValueOutstanding`	$3.00M	USD	Point-in-time
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 305,476,800 shares 2021 and 339,425,600 shares 2020	`CommonStockValueOutstanding`	$3.00M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapitalCommonStock`	-	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapitalCommonStock`	$294.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-381.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-404.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-502.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-460.00M	USD	Point-in-time
Retained earnings (deficit)	`RetainedEarningsAccumulatedDeficit`	$-532.00M	USD	Point-in-time
Retained earnings (deficit)	`RetainedEarningsAccumulatedDeficit`	$777.00M	USD	Point-in-time
Stockholders' equity (deficit) attributable to HCA Healthcare, Inc.	`StockholdersEquity`	$-933.00M	USD	Point-in-time
Stockholders' equity (deficit) attributable to HCA Healthcare, Inc.	`StockholdersEquity`	$572.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.42B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.32B	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-565.00M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.89B	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.92B	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.49B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$47.49B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$50.74B	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$51.53B	USD	Annual
Revenues	`Revenues`	$51.34B	USD	Annual
Revenues	`Revenues`	$58.75B	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$26.78B	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$23.87B	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$23.56B	USD	Annual
Supplies	`SuppliesExpense`	$8.37B	USD	Annual
Supplies	`SuppliesExpense`	$9.48B	USD	Annual
Supplies	`SuppliesExpense`	$8.48B	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$9.96B	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$9.31B	USD	Annual
Other operating expenses	`OtherCostAndExpenseOperating`	$9.48B	USD	Annual
Equity in earnings of affiliates	`IncomeLossFromEquityMethodInvestments`	$113.00M	USD	Annual
Equity in earnings of affiliates	`IncomeLossFromEquityMethodInvestments`	$43.00M	USD	Annual
Equity in earnings of affiliates	`IncomeLossFromEquityMethodInvestments`	$54.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.60B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.72B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.85B	USD	Annual
Interest expense	`InterestExpense`	$1.57B	USD	Annual
Interest expense	`InterestExpense`	$1.58B	USD	Annual
Interest expense	`InterestExpense`	$1.82B	USD	Annual
Losses (gains) on sales of facilities	`GainLossOnDispositionOfAssets`	$18.00M	USD	Annual
Losses (gains) on sales of facilities	`GainLossOnDispositionOfAssets`	$1.62B	USD	Annual
Losses (gains) on sales of facilities	`GainLossOnDispositionOfAssets`	$-7.00M	USD	Annual
Losses on retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-295.00M	USD	Annual
Losses on retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-211.00M	USD	Annual
Losses on retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-12.00M	USD	Annual
Total expenses including equity in earnings of affiliates	`CostsAndExpenses`	$46.10B	USD	Annual
Total expenses including equity in earnings of affiliates	`CostsAndExpenses`	$48.92B	USD	Annual
Total expenses including equity in earnings of affiliates	`CostsAndExpenses`	$46.09B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.24B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.83B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.43B	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.10B	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.04B	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.11B	USD	Annual
Net income	`ProfitLoss`	$4.14B	USD	Annual
Net income	`ProfitLoss`	$4.39B	USD	Annual
Net income	`ProfitLoss`	$7.72B	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$640.00M	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$633.00M	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$765.00M	USD	Annual
Net income attributable to HCA Healthcare, Inc.	`NetIncomeLoss`	$6.96B	USD	Annual
Net income attributable to HCA Healthcare, Inc.	`NetIncomeLoss`	$3.50B	USD	Annual
Net income attributable to HCA Healthcare, Inc.	`NetIncomeLoss`	$3.75B	USD	Annual
Basic earnings per share	`EarningsPerShareBasic`	$21.52	USD	Annual
Basic earnings per share	`EarningsPerShareBasic`	$11.10	USD	Annual
Basic earnings per share	`EarningsPerShareBasic`	$10.27	USD	Annual
Diluted earnings per share	`EarningsPerShareDiluted`	$10.07	USD	Annual
Diluted earnings per share	`EarningsPerShareDiluted`	$21.16	USD	Annual
Diluted earnings per share	`EarningsPerShareDiluted`	$10.93	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	323.31M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	338.27M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	341.21M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	343.61M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	328.75M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	348.23M	shares	Annual

Cash Flow Statement 101 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$4.14B	USD	Annual
Net income	`ProfitLoss`	$4.39B	USD	Annual
Net income	`ProfitLoss`	$7.72B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$962.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-327.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$326.00M	USD	Annual
Inventories and other assets	`IncreaseDecreaseInInventoriesAndOtherOperatingAssets`	$158.00M	USD	Annual
Inventories and other assets	`IncreaseDecreaseInInventoriesAndOtherOperatingAssets`	$304.00M	USD	Annual
Inventories and other assets	`IncreaseDecreaseInInventoriesAndOtherOperatingAssets`	$540.00M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.25B	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$999.00M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$396.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.60B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.72B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.85B	USD	Annual
Income taxes	`DeferredIncomeTaxesAndTaxCredits`	$41.00M	USD	Annual
Income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-70.00M	USD	Annual
Income taxes	`DeferredIncomeTaxesAndTaxCredits`	$250.00M	USD	Annual
Losses (gains) on sales of facilities	`GainLossOnDispositionOfAssets`	$18.00M	USD	Annual
Losses (gains) on sales of facilities	`GainLossOnDispositionOfAssets`	$1.62B	USD	Annual
Losses (gains) on sales of facilities	`GainLossOnDispositionOfAssets`	$-7.00M	USD	Annual
Losses on retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-295.00M	USD	Annual
Losses on retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-211.00M	USD	Annual
Losses on retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-12.00M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$27.00M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$30.00M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$30.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$440.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$347.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$362.00M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-129.00M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-99.00M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-111.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.60B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.96B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.23B	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.83B	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.58B	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.16B	USD	Annual
Acquisition of hospitals and health care entities	`PaymentsToAcquireInterestInSubsidiariesAndAffiliates`	$568.00M	USD	Annual
Acquisition of hospitals and health care entities	`PaymentsToAcquireInterestInSubsidiariesAndAffiliates`	$1.68B	USD	Annual
Acquisition of hospitals and health care entities	`PaymentsToAcquireInterestInSubsidiariesAndAffiliates`	$1.10B	USD	Annual
Sales of hospitals and health care entities	`ProceedsFromDivestitureOfBusinesses`	$61.00M	USD	Annual
Sales of hospitals and health care entities	`ProceedsFromDivestitureOfBusinesses`	$2.16B	USD	Annual
Sales of hospitals and health care entities	`ProceedsFromDivestitureOfBusinesses`	$68.00M	USD	Annual
Change in investments	`PaymentsForProceedsFromInvestments`	$117.00M	USD	Annual
Change in investments	`PaymentsForProceedsFromInvestments`	$-25.00M	USD	Annual
Change in investments	`PaymentsForProceedsFromInvestments`	$20.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-34.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$38.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.64B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.39B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.72B	USD	Annual
Issuances of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$6.45B	USD	Annual
Issuances of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.70B	USD	Annual
Issuances of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$4.34B	USD	Annual
Net change in revolving credit facilities	`ProceedsFromRepaymentsOfLinesOfCredit`	$-2.48B	USD	Annual
Net change in revolving credit facilities	`ProceedsFromRepaymentsOfLinesOfCredit`	$2.78B	USD	Annual
Net change in revolving credit facilities	`ProceedsFromRepaymentsOfLinesOfCredit`	$-560.00M	USD	Annual
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$3.44B	USD	Annual
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$5.32B	USD	Annual
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$3.87B	USD	Annual
Distributions to noncontrolling interests	`PaymentsToMinorityShareholders`	$542.00M	USD	Annual
Distributions to noncontrolling interests	`PaymentsToMinorityShareholders`	$749.00M	USD	Annual
Distributions to noncontrolling interests	`PaymentsToMinorityShareholders`	$626.00M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$38.00M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$35.00M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$73.00M	USD	Annual
Payment of dividends	`PaymentsOfDividends`	$624.00M	USD	Annual
Payment of dividends	`PaymentsOfDividends`	$153.00M	USD	Annual
Payment of dividends	`PaymentsOfDividends`	$550.00M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.03B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$8.21B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$441.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-284.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-205.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-142.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.68B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.77B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.66B	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-3.00M	USD	Annual
Change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.17B	USD	Annual
Change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-342.00M	USD	Annual
Change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$119.00M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.45B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$621.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$502.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.79B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.45B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$621.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$502.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.79B	USD	Point-in-time
Interest payments	`InterestPaidNet`	$1.50B	USD	Annual
Interest payments	`InterestPaidNet`	$1.61B	USD	Annual
Interest payments	`InterestPaidNet`	$1.91B	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$849.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$2.18B	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$1.00B	USD	Annual

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared, per share	`CommonStockDividendsPerShareDeclared`	$0.43	USD	Annual
Cash dividends declared, per share	`CommonStockDividendsPerShareDeclared`	$1.92	USD	Annual
Cash dividends declared, per share	`CommonStockDividendsPerShareDeclared`	$1.60	USD	Annual
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-565.00M	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.89B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.92B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.49B	USD	Point-in-time
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.07B	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.82B	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.34B	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$1.03B	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$8.21B	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$441.00M	USD	Annual
Repurchase of common stock, shares	`StockRepurchasedDuringPeriodShares`	37.81M	shares	Annual
Repurchase of common stock, shares	`StockRepurchasedDuringPeriodShares`	7.95M	shares	Annual
Repurchase of common stock, shares	`StockRepurchasedDuringPeriodShares`	3.29M	shares	Annual
Share-based benefit plans	`StockGrantedDuringPeriodValueSharebasedCompensation`	$313.00M	USD	Annual
Share-based benefit plans	`StockGrantedDuringPeriodValueSharebasedCompensation`	$265.00M	USD	Annual
Share-based benefit plans	`StockGrantedDuringPeriodValueSharebasedCompensation`	$280.00M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$555.00M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$150.00M	USD	Annual
Cash dividends declared	`DividendsCommonStockCash`	$628.00M	USD	Annual
Distributions	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$626.00M	USD	Annual
Distributions	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$542.00M	USD	Annual
Distributions	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$749.00M	USD	Annual
Other	`StockholdersEquityOther`	$-90.00M	USD	Annual
Other	`StockholdersEquityOther`	$-64.00M	USD	Annual
Other	`StockholdersEquityOther`	$-102.00M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-565.00M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.89B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.92B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.49B	USD	Point-in-time

Comprehensive Income 45 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$4.14B	USD	Annual
Net income	`ProfitLoss`	$4.39B	USD	Annual
Net income	`ProfitLoss`	$7.72B	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$5.00M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-9.00M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$18.00M	USD	Annual
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$14.00M	USD	Annual
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$15.00M	USD	Annual
Unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-16.00M	USD	Annual
Defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax`	$-63.00M	USD	Annual
Defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax`	$87.00M	USD	Annual
Defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax`	$-71.00M	USD	Annual
Pension costs included in salaries and benefits	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax`	$-13.00M	USD	Annual
Pension costs included in salaries and benefits	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax`	$-28.00M	USD	Annual
Pension costs included in salaries and benefits	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax`	$-28.00M	USD	Annual
Total defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$-115.00M	USD	Annual
Total defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$43.00M	USD	Annual
Total defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$50.00M	USD	Annual
Change in fair value of derivative financial instruments	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax`	$1.00M	USD	Annual
Change in fair value of derivative financial instruments	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax`	$-66.00M	USD	Annual
Change in fair value of derivative financial instruments	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax`	$-50.00M	USD	Annual
Interest costs (benefits) included in interest expense	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax`	$-24.00M	USD	Annual
Interest costs (benefits) included in interest expense	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax`	$-37.00M	USD	Annual
Interest costs (benefits) included in interest expense	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax`	$17.00M	USD	Annual
Total change in fair value of derivative financial instruments	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTax`	$-67.00M	USD	Annual
Total change in fair value of derivative financial instruments	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTax`	$38.00M	USD	Annual
Total change in fair value of derivative financial instruments	`OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTax`	$-42.00M	USD	Annual
Other comprehensive income (loss) before taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-97.00M	USD	Annual
Other comprehensive income (loss) before taxes	`OtherComprehensiveIncomeLossBeforeTax`	$128.00M	USD	Annual
Other comprehensive income (loss) before taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-53.00M	USD	Annual
Income taxes (benefits) related to other comprehensive income items	`OtherComprehensiveIncomeLossTax`	$-18.00M	USD	Annual
Income taxes (benefits) related to other comprehensive income items	`OtherComprehensiveIncomeLossTax`	$30.00M	USD	Annual
Income taxes (benefits) related to other comprehensive income items	`OtherComprehensiveIncomeLossTax`	$-11.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-79.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-42.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$98.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.07B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.82B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.34B	USD	Annual
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$765.00M	USD	Annual
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$640.00M	USD	Annual
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$633.00M	USD	Annual
Comprehensive income attributable to HCA Healthcare, Inc.	`ComprehensiveIncomeNetOfTax`	$7.05B	USD	Annual
Comprehensive income attributable to HCA Healthcare, Inc.	`ComprehensiveIncomeNetOfTax`	$3.43B	USD	Annual
Comprehensive income attributable to HCA Healthcare, Inc.	`ComprehensiveIncomeNetOfTax`	$3.71B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.